CN116323578A - 噻吩hsd17b13抑制剂及其用途 - Google Patents
噻吩hsd17b13抑制剂及其用途 Download PDFInfo
- Publication number
- CN116323578A CN116323578A CN202180065663.XA CN202180065663A CN116323578A CN 116323578 A CN116323578 A CN 116323578A CN 202180065663 A CN202180065663 A CN 202180065663A CN 116323578 A CN116323578 A CN 116323578A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- heterocycloalkyl
- aryl
- cycloalkyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063056165P | 2020-07-24 | 2020-07-24 | |
| US63/056,165 | 2020-07-24 | ||
| US202063113555P | 2020-11-13 | 2020-11-13 | |
| US63/113,555 | 2020-11-13 | ||
| PCT/US2021/042960 WO2022020714A1 (en) | 2020-07-24 | 2021-07-23 | Thiophene hsd17b13 inhibitors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116323578A true CN116323578A (zh) | 2023-06-23 |
Family
ID=79729016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180065663.XA Pending CN116323578A (zh) | 2020-07-24 | 2021-07-23 | 噻吩hsd17b13抑制剂及其用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12673930B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4185381A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023537271A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116323578A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202220967A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022020714A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023537271A (ja) | 2020-07-24 | 2023-08-31 | イニファーム,インク. | チオフェンhsd17b13阻害剤とその使用 |
| CN116670118B (zh) | 2020-11-13 | 2026-02-06 | 伊尼制药公司 | 二氯苯酚hsd17b13抑制剂及其用途 |
| US12617772B2 (en) | 2021-04-05 | 2026-05-05 | Inipharm, Inc. | Hydroxypyridine HSD17B13 inhibitors and uses thereof |
| CA3229569A1 (en) | 2021-08-20 | 2023-02-23 | Enanta Pharmaceuticals, Inc. | 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof |
| CN118647606A (zh) * | 2021-12-15 | 2024-09-13 | 百时美施贵宝公司 | 作为rxfp1激动剂的苯并噻吩衍生物 |
| EP4469451A4 (en) * | 2022-01-26 | 2025-12-24 | Inipharm Inc | HSD17B13 2-SUBSTITUTE THIAZOLES INHIBITORS AND RELATED USES |
| HRP20251564T1 (hr) * | 2022-05-19 | 2026-01-30 | Astrazeneca Ab | Amidni heteroaromatski spojevi korisni u liječenju bolesti jetre |
| US20250340546A1 (en) | 2022-06-09 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Hsd17b13 inhibitors |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1233246A (zh) * | 1996-10-15 | 1999-10-27 | 默克专利股份公司 | 氨基噻吩羧基酰胺及其作为磷酸二酯酶抑制剂的用途 |
| US20060217426A1 (en) * | 2003-03-27 | 2006-09-28 | Kirin Beer Kabushiki Kaisha | Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| CN101287728A (zh) * | 2005-08-17 | 2008-10-15 | 先灵公司 | 新的高亲和力噻吩基和呋喃基激酶配体 |
| US20150119426A1 (en) * | 2012-05-04 | 2015-04-30 | The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services | Modulators of the relaxin receptor 1 |
| CN105524053A (zh) * | 2014-10-19 | 2016-04-27 | 广东东阳光药业有限公司 | 四氢苯并噻吩化合物 |
| US20170096435A1 (en) * | 2015-09-30 | 2017-04-06 | Quartet Medicine, Inc. | Sepiapterin reductase inhibitors |
| KR20170092126A (ko) * | 2016-02-02 | 2017-08-10 | 부산대학교 산학협력단 | Ppar, fxr 및 ampk 활성화 효능을 갖는 신규 티오펜 화합물 또는 이의 약제학적으로 허용 가능한 염 및 이의 의학적 용도 |
| CN109563070A (zh) * | 2016-08-15 | 2019-04-02 | 伊莱利利公司 | 作为napi-iib抑制剂的稠合噻吩衍生物 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2694711A (en) | 1952-12-02 | 1954-11-16 | American Cyanamid Co | Quinazolone antimalarial compounds |
| US6204261B1 (en) | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| JP2008506761A (ja) | 2004-07-22 | 2008-03-06 | アステックス、セラピューティックス、リミテッド | プロテインキナーゼ阻害剤としてのチアゾールおよびイソチアゾール誘導体 |
| US20070010537A1 (en) | 2004-08-20 | 2007-01-11 | Kazumasa Hamamura | Fused pyramidine derivative and use thereof |
| WO2006040966A1 (ja) | 2004-10-08 | 2006-04-20 | Astellas Pharma Inc. | 芳香環縮合ピリミジン誘導体 |
| US20090163521A1 (en) | 2005-06-28 | 2009-06-25 | Orchid Research Laboratories Limited | Novel Pyrazolopyrimidinone Derivatives |
| GB0513702D0 (en) | 2005-07-04 | 2005-08-10 | Sterix Ltd | Compound |
| HUE035389T2 (en) | 2006-09-26 | 2018-05-02 | Celgene Corp | 5-substituted quinazolinone derivatives as anticancer agents |
| US20080255161A1 (en) | 2007-04-11 | 2008-10-16 | Dmitry Koltun | 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| US8703768B2 (en) | 2010-06-09 | 2014-04-22 | Hoffmann-La Roche Inc. | Nitrogen containing heteroaryl compounds |
| US8440665B2 (en) | 2010-07-02 | 2013-05-14 | Gilead Sciences, Inc. | Apoptosis signal-regulating kinase inhibitors |
| US20120165330A1 (en) | 2010-12-22 | 2012-06-28 | Sirtris Pharmaceuticals, Inc. | Quinazolinone and related analogs as sirtuin modulators |
| CA2831978A1 (en) * | 2011-03-03 | 2012-09-07 | Universitat Des Saarlandes | Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors |
| CN103288771B (zh) | 2012-02-29 | 2014-12-03 | 中国中化股份有限公司 | 异噻唑类化合物及其作为杀菌剂的用途 |
| AU2014205043B2 (en) | 2013-01-14 | 2018-10-04 | Deuterx, Llc | 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives |
| WO2016081522A1 (en) | 2014-11-17 | 2016-05-26 | Rhode Island Hospital | Nanomaterial compositions, synthesis, and assembly |
| EP3404024B1 (en) | 2016-01-14 | 2020-11-18 | Kangpu Biopharmaceuticals, Ltd. | Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications |
| TWI762634B (zh) * | 2017-05-05 | 2022-05-01 | 大陸商上海赫普化醫藥技術有限公司 | 胺基-芳基-苯甲醯胺化合物及其使用方法 |
| EA202091897A1 (ru) * | 2018-02-08 | 2020-10-27 | Энио Фарма | Неконденсированные производные тиофена и их применение |
| US20210000906A1 (en) * | 2018-03-21 | 2021-01-07 | Ionis Pharmaceuticals, Inc. | Modulation of hsd17b13 expression |
| WO2020041741A1 (en) | 2018-08-24 | 2020-02-27 | Terns, Inc. | Thyroid hormone receptor beta agonist compounds |
| MA56457A (fr) | 2019-07-02 | 2022-05-11 | Regeneron Pharma | Modulateurs de hsd17b13 et leurs procédés d'utilisation |
| JP2023537271A (ja) | 2020-07-24 | 2023-08-31 | イニファーム,インク. | チオフェンhsd17b13阻害剤とその使用 |
| CN116194440A (zh) | 2020-07-24 | 2023-05-30 | 伊尼制药公司 | 喹唑啉酮hsd17b13抑制剂及其用途 |
| IL299972A (en) | 2020-08-05 | 2023-03-01 | Enyo Pharma | Thiophane compounds for use in the treatment of renal fibrosis |
| WO2022040324A1 (en) | 2020-08-18 | 2022-02-24 | Metrea Biosciences, Inc. | COMPOUNDS AND METHODS OF MODULATING 17β-ΗYDROXYSTEROID DEHYDROGENASE TYPE 13 |
| MX2023003677A (es) | 2020-09-30 | 2023-06-22 | Fl2022 001 Inc | Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos. |
| US20240083861A1 (en) | 2020-09-30 | 2024-03-14 | Fl2022-001, Inc. | Hsd17b13 inhibitors and uses thereof |
| EP4221701A1 (en) | 2020-09-30 | 2023-08-09 | FL2022-001, Inc. | Hsd17b13 inhibitors and uses thereof |
| US20230416802A1 (en) | 2020-11-06 | 2023-12-28 | Inipharm, Inc. | Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatment |
| CN116670118B (zh) | 2020-11-13 | 2026-02-06 | 伊尼制药公司 | 二氯苯酚hsd17b13抑制剂及其用途 |
| EP4319872A4 (en) | 2021-04-05 | 2025-03-12 | Inipharm, Inc. | Thiazole/isothiazole hsd17b13 inhibitors and uses thereof |
| US12617772B2 (en) | 2021-04-05 | 2026-05-05 | Inipharm, Inc. | Hydroxypyridine HSD17B13 inhibitors and uses thereof |
| CA3229569A1 (en) | 2021-08-20 | 2023-02-23 | Enanta Pharmaceuticals, Inc. | 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof |
| EP4469451A4 (en) | 2022-01-26 | 2025-12-24 | Inipharm Inc | HSD17B13 2-SUBSTITUTE THIAZOLES INHIBITORS AND RELATED USES |
| US20250340546A1 (en) | 2022-06-09 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Hsd17b13 inhibitors |
| CN118955491A (zh) | 2024-09-04 | 2024-11-15 | 广东药科大学 | 一类新型噻唑类hsd17b13抑制剂、其制备方法及其作为药物的用途 |
-
2021
- 2021-07-23 JP JP2023504724A patent/JP2023537271A/ja active Pending
- 2021-07-23 WO PCT/US2021/042960 patent/WO2022020714A1/en not_active Ceased
- 2021-07-23 US US18/006,059 patent/US12673930B2/en active Active
- 2021-07-23 CN CN202180065663.XA patent/CN116323578A/zh active Pending
- 2021-07-23 TW TW110127231A patent/TW202220967A/zh unknown
- 2021-07-23 EP EP21846586.2A patent/EP4185381A4/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1233246A (zh) * | 1996-10-15 | 1999-10-27 | 默克专利股份公司 | 氨基噻吩羧基酰胺及其作为磷酸二酯酶抑制剂的用途 |
| US20060217426A1 (en) * | 2003-03-27 | 2006-09-28 | Kirin Beer Kabushiki Kaisha | Compound inhibiting in vivo phosphorous transport and medicine containing the same |
| CN101287728A (zh) * | 2005-08-17 | 2008-10-15 | 先灵公司 | 新的高亲和力噻吩基和呋喃基激酶配体 |
| US20150119426A1 (en) * | 2012-05-04 | 2015-04-30 | The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services | Modulators of the relaxin receptor 1 |
| CN105524053A (zh) * | 2014-10-19 | 2016-04-27 | 广东东阳光药业有限公司 | 四氢苯并噻吩化合物 |
| US20170096435A1 (en) * | 2015-09-30 | 2017-04-06 | Quartet Medicine, Inc. | Sepiapterin reductase inhibitors |
| KR20170092126A (ko) * | 2016-02-02 | 2017-08-10 | 부산대학교 산학협력단 | Ppar, fxr 및 ampk 활성화 효능을 갖는 신규 티오펜 화합물 또는 이의 약제학적으로 허용 가능한 염 및 이의 의학적 용도 |
| CN109563070A (zh) * | 2016-08-15 | 2019-04-02 | 伊莱利利公司 | 作为napi-iib抑制剂的稠合噻吩衍生物 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022020714A1 (en) | 2022-01-27 |
| EP4185381A4 (en) | 2024-08-21 |
| JP2023537271A (ja) | 2023-08-31 |
| US20230278978A1 (en) | 2023-09-07 |
| US12673930B2 (en) | 2026-07-07 |
| EP4185381A1 (en) | 2023-05-31 |
| TW202220967A (zh) | 2022-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4185381A1 (en) | Thiophene hsd17b13 inhibitors and uses thereof | |
| CN116670118B (zh) | 二氯苯酚hsd17b13抑制剂及其用途 | |
| CN116194440A (zh) | 喹唑啉酮hsd17b13抑制剂及其用途 | |
| WO2021211974A1 (en) | Hsd17b13 inhibitors and uses thereof | |
| US12617772B2 (en) | Hydroxypyridine HSD17B13 inhibitors and uses thereof | |
| WO2022216627A1 (en) | Thiazole/isothiazole hsd17b13 inhibitors and uses thereof | |
| CN119032090A (zh) | 2-取代的噻唑hsd17b13抑制剂及其用途 | |
| CN107759588A (zh) | 一类苯基‑(吡唑并[1,5‑a]吡啶‑3‑基)甲酮衍生物 | |
| HK40097014B (en) | Dichlorophenol hsd17b13 inhibitors and uses thereof | |
| HK40094120A (en) | Quinazolinone hsd17b13 inhibitors and uses thereof | |
| HK40097014A (zh) | 二氯苯酚hsd17b13抑制剂及其用途 | |
| WO2026064458A1 (en) | Hsd17b13 inhibitors and uses thereof | |
| TW202413358A (zh) | 用於抑制pkmyt1之化合物及方法 | |
| EA049239B1 (ru) | Дихлорфенольные ингибиторы hsd17b13 и их применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40095049 Country of ref document: HK |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230623 |